nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—systemic scleroderma	0.237	1	CiPCiCtD
Betamethasone—Mometasone—systemic scleroderma	0.144	0.647	CrCtD
Betamethasone—Prednisone—systemic scleroderma	0.0787	0.353	CrCtD
Betamethasone—ankylosing spondylitis—systemic scleroderma	0.066	0.277	CtDrD
Betamethasone—systemic lupus erythematosus—systemic scleroderma	0.0629	0.264	CtDrD
Betamethasone—rheumatoid arthritis—systemic scleroderma	0.0594	0.25	CtDrD
Betamethasone—psoriasis—systemic scleroderma	0.0498	0.209	CtDrD
Betamethasone—NR3C1—Mometasone—systemic scleroderma	0.0433	0.527	CbGbCtD
Betamethasone—NR3C1—Prednisone—systemic scleroderma	0.0138	0.168	CbGbCtD
Betamethasone—ABCB1—Lisinopril—systemic scleroderma	0.00681	0.0829	CbGbCtD
Betamethasone—ABCB1—Captopril—systemic scleroderma	0.0051	0.0621	CbGbCtD
Betamethasone—Fluticasone furoate—Mometasone—systemic scleroderma	0.00491	0.0296	CrCrCtD
Betamethasone—Flumethasone Pivalate—Mometasone—systemic scleroderma	0.00442	0.0266	CrCrCtD
Betamethasone—Halobetasol Propionate—Mometasone—systemic scleroderma	0.00427	0.0257	CrCrCtD
Betamethasone—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00427	0.0257	CrCrCtD
Betamethasone—Difluprednate—Mometasone—systemic scleroderma	0.00427	0.0257	CrCrCtD
Betamethasone—Clocortolone—Mometasone—systemic scleroderma	0.00402	0.0242	CrCrCtD
Betamethasone—Beclomethasone—Mometasone—systemic scleroderma	0.00402	0.0242	CrCrCtD
Betamethasone—Fluocinonide—Mometasone—systemic scleroderma	0.00402	0.0242	CrCrCtD
Betamethasone—Testolactone—Mometasone—systemic scleroderma	0.00402	0.0242	CrCrCtD
Betamethasone—Prednicarbate—Mometasone—systemic scleroderma	0.00402	0.0242	CrCrCtD
Betamethasone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00401	0.0489	CbGbCtD
Betamethasone—Fluocortolone—Mometasone—systemic scleroderma	0.0039	0.0235	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.00379	0.0228	CrCrCtD
Betamethasone—Alclometasone—Mometasone—systemic scleroderma	0.00379	0.0228	CrCrCtD
Betamethasone—Fluoxymesterone—Mometasone—systemic scleroderma	0.00369	0.0222	CrCrCtD
Betamethasone—Budesonide—Mometasone—systemic scleroderma	0.00369	0.0222	CrCrCtD
Betamethasone—Amcinonide—Mometasone—systemic scleroderma	0.00369	0.0222	CrCrCtD
Betamethasone—Clobetasol propionate—Mometasone—systemic scleroderma	0.0036	0.0217	CrCrCtD
Betamethasone—Flunisolide—Mometasone—systemic scleroderma	0.0036	0.0217	CrCrCtD
Betamethasone—Fludrocortisone—Mometasone—systemic scleroderma	0.0036	0.0217	CrCrCtD
Betamethasone—Diflorasone—Mometasone—systemic scleroderma	0.0036	0.0217	CrCrCtD
Betamethasone—Prednisone—Mometasone—systemic scleroderma	0.0036	0.0217	CrCrCtD
Betamethasone—Desonide—Mometasone—systemic scleroderma	0.0036	0.0217	CrCrCtD
Betamethasone—Paramethasone—Mometasone—systemic scleroderma	0.00351	0.0211	CrCrCtD
Betamethasone—Desoximetasone—Mometasone—systemic scleroderma	0.00342	0.0206	CrCrCtD
Betamethasone—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.00334	0.0201	CrCrCtD
Betamethasone—Triamcinolone—Mometasone—systemic scleroderma	0.00334	0.0201	CrCrCtD
Betamethasone—Fluorometholone—Mometasone—systemic scleroderma	0.00334	0.0201	CrCrCtD
Betamethasone—Loteprednol—Mometasone—systemic scleroderma	0.00334	0.0201	CrCrCtD
Betamethasone—Rimexolone—Mometasone—systemic scleroderma	0.00326	0.0197	CrCrCtD
Betamethasone—Dexamethasone—Mometasone—systemic scleroderma	0.00326	0.0197	CrCrCtD
Betamethasone—ABCB1—Prednisone—systemic scleroderma	0.00321	0.0391	CbGbCtD
Betamethasone—Methylprednisolone—Mometasone—systemic scleroderma	0.00312	0.0188	CrCrCtD
Betamethasone—Prednisolone—Mometasone—systemic scleroderma	0.00306	0.0184	CrCrCtD
Betamethasone—Hydrocortisone—Mometasone—systemic scleroderma	0.00293	0.0177	CrCrCtD
Betamethasone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0024	0.0293	CbGbCtD
Betamethasone—Prednicarbate—Prednisone—systemic scleroderma	0.00219	0.0132	CrCrCtD
Betamethasone—Testolactone—Prednisone—systemic scleroderma	0.00219	0.0132	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—systemic scleroderma	0.00213	0.0128	CrCrCtD
Betamethasone—Alclometasone—Prednisone—systemic scleroderma	0.00207	0.0124	CrCrCtD
Betamethasone—Amcinonide—Prednisone—systemic scleroderma	0.00201	0.0121	CrCrCtD
Betamethasone—Budesonide—Prednisone—systemic scleroderma	0.00201	0.0121	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—systemic scleroderma	0.00196	0.0118	CrCrCtD
Betamethasone—Desonide—Prednisone—systemic scleroderma	0.00196	0.0118	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—systemic scleroderma	0.00196	0.0118	CrCrCtD
Betamethasone—Flunisolide—Prednisone—systemic scleroderma	0.00196	0.0118	CrCrCtD
Betamethasone—Diflorasone—Prednisone—systemic scleroderma	0.00196	0.0118	CrCrCtD
Betamethasone—CYP3A4—Prednisone—systemic scleroderma	0.00192	0.0234	CbGbCtD
Betamethasone—Paramethasone—Prednisone—systemic scleroderma	0.00191	0.0115	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—systemic scleroderma	0.00187	0.0112	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—systemic scleroderma	0.00182	0.011	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00182	0.011	CrCrCtD
Betamethasone—Mometasone—Prednisone—systemic scleroderma	0.00182	0.011	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—systemic scleroderma	0.00182	0.011	CrCrCtD
Betamethasone—Loteprednol—Prednisone—systemic scleroderma	0.00182	0.011	CrCrCtD
Betamethasone—Dexamethasone—Prednisone—systemic scleroderma	0.00178	0.0107	CrCrCtD
Betamethasone—Rimexolone—Prednisone—systemic scleroderma	0.00178	0.0107	CrCrCtD
Betamethasone—Methylprednisolone—Prednisone—systemic scleroderma	0.0017	0.0102	CrCrCtD
Betamethasone—Prednisolone—Prednisone—systemic scleroderma	0.00167	0.01	CrCrCtD
Betamethasone—ABCB1—Methotrexate—systemic scleroderma	0.00161	0.0196	CbGbCtD
Betamethasone—Hydrocortisone—Prednisone—systemic scleroderma	0.0016	0.00963	CrCrCtD
Betamethasone—PLA2G1B—blood vessel—systemic scleroderma	0.000971	0.124	CbGeAlD
Betamethasone—PTGS2—skeletal joint—systemic scleroderma	0.000684	0.0874	CbGeAlD
Betamethasone—PGR—artery—systemic scleroderma	0.000574	0.0732	CbGeAlD
Betamethasone—PLA2G1B—connective tissue—systemic scleroderma	0.000498	0.0636	CbGeAlD
Betamethasone—PGR—blood vessel—systemic scleroderma	0.000447	0.0571	CbGeAlD
Betamethasone—PLA2G1B—digestive system—systemic scleroderma	0.000359	0.0459	CbGeAlD
Betamethasone—PLA2G1B—lung—systemic scleroderma	0.0003	0.0383	CbGeAlD
Betamethasone—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000299	0.624	CbGdCrCtD
Betamethasone—PTGS2—artery—systemic scleroderma	0.000286	0.0366	CbGeAlD
Betamethasone—NR3C2—connective tissue—systemic scleroderma	0.000246	0.0315	CbGeAlD
Betamethasone—PTGS2—endothelium—systemic scleroderma	0.000242	0.0309	CbGeAlD
Betamethasone—PGR—connective tissue—systemic scleroderma	0.000229	0.0293	CbGeAlD
Betamethasone—NR3C2—smooth muscle tissue—systemic scleroderma	0.000225	0.0288	CbGeAlD
Betamethasone—PTGS2—blood vessel—systemic scleroderma	0.000223	0.0285	CbGeAlD
Betamethasone—PGR—smooth muscle tissue—systemic scleroderma	0.00021	0.0268	CbGeAlD
Betamethasone—CYP19A1—connective tissue—systemic scleroderma	0.000206	0.0263	CbGeAlD
Betamethasone—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00018	0.376	CbGdCrCtD
Betamethasone—NR3C2—digestive system—systemic scleroderma	0.000178	0.0227	CbGeAlD
Betamethasone—NR3C2—tendon—systemic scleroderma	0.000169	0.0216	CbGeAlD
Betamethasone—NR3C2—lung—systemic scleroderma	0.000149	0.019	CbGeAlD
Betamethasone—PGR—lung—systemic scleroderma	0.000138	0.0176	CbGeAlD
Betamethasone—ABCB1—blood vessel—systemic scleroderma	0.000138	0.0176	CbGeAlD
Betamethasone—NR3C1—connective tissue—systemic scleroderma	0.000132	0.0169	CbGeAlD
Betamethasone—NR3C1—smooth muscle tissue—systemic scleroderma	0.000121	0.0154	CbGeAlD
Betamethasone—NR3C1—skin of body—systemic scleroderma	0.000119	0.0152	CbGeAlD
Betamethasone—PTGS2—connective tissue—systemic scleroderma	0.000114	0.0146	CbGeAlD
Betamethasone—PTGS2—smooth muscle tissue—systemic scleroderma	0.000105	0.0134	CbGeAlD
Betamethasone—PTGS2—skin of body—systemic scleroderma	0.000103	0.0132	CbGeAlD
Betamethasone—NR3C1—digestive system—systemic scleroderma	9.55e-05	0.0122	CbGeAlD
Betamethasone—NR3C1—tendon—systemic scleroderma	9.09e-05	0.0116	CbGeAlD
Betamethasone—PTGS2—digestive system—systemic scleroderma	8.26e-05	0.0106	CbGeAlD
Betamethasone—NR3C1—lung—systemic scleroderma	7.97e-05	0.0102	CbGeAlD
Betamethasone—PTGS2—tendon—systemic scleroderma	7.86e-05	0.01	CbGeAlD
Betamethasone—CYP3A4—digestive system—systemic scleroderma	7.22e-05	0.00922	CbGeAlD
Betamethasone—PTGS2—lung—systemic scleroderma	6.9e-05	0.00881	CbGeAlD
Betamethasone—ABCB1—digestive system—systemic scleroderma	5.11e-05	0.00653	CbGeAlD
Betamethasone—ABCB1—lung—systemic scleroderma	4.27e-05	0.00545	CbGeAlD
Betamethasone—Gastrointestinal disorder—Azathioprine—systemic scleroderma	2.21e-05	0.000488	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	2.2e-05	0.000487	CcSEcCtD
Betamethasone—Anorexia—Mycophenolic acid—systemic scleroderma	2.19e-05	0.000486	CcSEcCtD
Betamethasone—Insomnia—Leflunomide—systemic scleroderma	2.18e-05	0.000483	CcSEcCtD
Betamethasone—Paraesthesia—Leflunomide—systemic scleroderma	2.17e-05	0.00048	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	2.16e-05	0.000479	CcSEcCtD
Betamethasone—Myalgia—Lisinopril—systemic scleroderma	2.16e-05	0.000479	CcSEcCtD
Betamethasone—Anxiety—Lisinopril—systemic scleroderma	2.16e-05	0.000477	CcSEcCtD
Betamethasone—Hypotension—Mycophenolic acid—systemic scleroderma	2.15e-05	0.000476	CcSEcCtD
Betamethasone—Discomfort—Lisinopril—systemic scleroderma	2.14e-05	0.000473	CcSEcCtD
Betamethasone—Lethargy—Methotrexate—systemic scleroderma	2.14e-05	0.000473	CcSEcCtD
Betamethasone—Dyspepsia—Leflunomide—systemic scleroderma	2.12e-05	0.00047	CcSEcCtD
Betamethasone—Vomiting—Mometasone—systemic scleroderma	2.12e-05	0.000469	CcSEcCtD
Betamethasone—Sweating increased—Prednisone—systemic scleroderma	2.11e-05	0.000467	CcSEcCtD
Betamethasone—Feeling abnormal—Azathioprine—systemic scleroderma	2.11e-05	0.000466	CcSEcCtD
Betamethasone—Rash—Mometasone—systemic scleroderma	2.1e-05	0.000465	CcSEcCtD
Betamethasone—Asthenia—Captopril—systemic scleroderma	2.1e-05	0.000465	CcSEcCtD
Betamethasone—Dermatitis—Mometasone—systemic scleroderma	2.1e-05	0.000465	CcSEcCtD
Betamethasone—Decreased appetite—Leflunomide—systemic scleroderma	2.1e-05	0.000464	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	2.1e-05	0.000464	CcSEcCtD
Betamethasone—Osteoarthritis—Methotrexate—systemic scleroderma	2.09e-05	0.000463	CcSEcCtD
Betamethasone—Gastrointestinal pain—Azathioprine—systemic scleroderma	2.09e-05	0.000462	CcSEcCtD
Betamethasone—Headache—Mometasone—systemic scleroderma	2.09e-05	0.000462	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	2.08e-05	0.000461	CcSEcCtD
Betamethasone—Insomnia—Mycophenolic acid—systemic scleroderma	2.08e-05	0.000461	CcSEcCtD
Betamethasone—Fatigue—Leflunomide—systemic scleroderma	2.08e-05	0.00046	CcSEcCtD
Betamethasone—Oedema—Lisinopril—systemic scleroderma	2.07e-05	0.000459	CcSEcCtD
Betamethasone—Anaphylactic shock—Lisinopril—systemic scleroderma	2.07e-05	0.000459	CcSEcCtD
Betamethasone—Pruritus—Captopril—systemic scleroderma	2.07e-05	0.000458	CcSEcCtD
Betamethasone—Paraesthesia—Mycophenolic acid—systemic scleroderma	2.07e-05	0.000457	CcSEcCtD
Betamethasone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	2.07e-05	0.000457	CcSEcCtD
Betamethasone—Pain—Leflunomide—systemic scleroderma	2.06e-05	0.000457	CcSEcCtD
Betamethasone—Infection—Lisinopril—systemic scleroderma	2.06e-05	0.000456	CcSEcCtD
Betamethasone—Shock—Lisinopril—systemic scleroderma	2.04e-05	0.000451	CcSEcCtD
Betamethasone—Angioedema—Mycophenolate mofetil—systemic scleroderma	2.03e-05	0.00045	CcSEcCtD
Betamethasone—Thrombocytopenia—Lisinopril—systemic scleroderma	2.03e-05	0.000449	CcSEcCtD
Betamethasone—Dyspepsia—Mycophenolic acid—systemic scleroderma	2.03e-05	0.000448	CcSEcCtD
Betamethasone—Tachycardia—Lisinopril—systemic scleroderma	2.02e-05	0.000448	CcSEcCtD
Betamethasone—Body temperature increased—Azathioprine—systemic scleroderma	2.02e-05	0.000447	CcSEcCtD
Betamethasone—Abdominal pain—Azathioprine—systemic scleroderma	2.02e-05	0.000447	CcSEcCtD
Betamethasone—Malaise—Mycophenolate mofetil—systemic scleroderma	2.01e-05	0.000444	CcSEcCtD
Betamethasone—Hyperhidrosis—Lisinopril—systemic scleroderma	2e-05	0.000444	CcSEcCtD
Betamethasone—Diarrhoea—Captopril—systemic scleroderma	2e-05	0.000443	CcSEcCtD
Betamethasone—Decreased appetite—Mycophenolic acid—systemic scleroderma	2e-05	0.000443	CcSEcCtD
Betamethasone—Vertigo—Mycophenolate mofetil—systemic scleroderma	2e-05	0.000443	CcSEcCtD
Betamethasone—Irritability—Methotrexate—systemic scleroderma	2e-05	0.000442	CcSEcCtD
Betamethasone—Syncope—Mycophenolate mofetil—systemic scleroderma	2e-05	0.000442	CcSEcCtD
Betamethasone—Feeling abnormal—Leflunomide—systemic scleroderma	1.99e-05	0.00044	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	1.99e-05	0.00044	CcSEcCtD
Betamethasone—Fatigue—Mycophenolic acid—systemic scleroderma	1.98e-05	0.000439	CcSEcCtD
Betamethasone—Mood swings—Methotrexate—systemic scleroderma	1.98e-05	0.000439	CcSEcCtD
Betamethasone—Nausea—Mometasone—systemic scleroderma	1.98e-05	0.000438	CcSEcCtD
Betamethasone—Anorexia—Lisinopril—systemic scleroderma	1.98e-05	0.000437	CcSEcCtD
Betamethasone—Gastrointestinal pain—Leflunomide—systemic scleroderma	1.97e-05	0.000437	CcSEcCtD
Betamethasone—Weight increased—Prednisone—systemic scleroderma	1.97e-05	0.000436	CcSEcCtD
Betamethasone—Pain—Mycophenolic acid—systemic scleroderma	1.97e-05	0.000436	CcSEcCtD
Betamethasone—Weight decreased—Prednisone—systemic scleroderma	1.96e-05	0.000434	CcSEcCtD
Betamethasone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	1.96e-05	0.000433	CcSEcCtD
Betamethasone—Hyperglycaemia—Prednisone—systemic scleroderma	1.95e-05	0.000432	CcSEcCtD
Betamethasone—Hypotension—Lisinopril—systemic scleroderma	1.94e-05	0.000429	CcSEcCtD
Betamethasone—Dizziness—Captopril—systemic scleroderma	1.94e-05	0.000428	CcSEcCtD
Betamethasone—Convulsion—Mycophenolate mofetil—systemic scleroderma	1.93e-05	0.000427	CcSEcCtD
Betamethasone—Hypertension—Mycophenolate mofetil—systemic scleroderma	1.92e-05	0.000425	CcSEcCtD
Betamethasone—Urticaria—Leflunomide—systemic scleroderma	1.92e-05	0.000424	CcSEcCtD
Betamethasone—Abdominal pain—Leflunomide—systemic scleroderma	1.91e-05	0.000422	CcSEcCtD
Betamethasone—Body temperature increased—Leflunomide—systemic scleroderma	1.91e-05	0.000422	CcSEcCtD
Betamethasone—Acute coronary syndrome—Prednisone—systemic scleroderma	1.9e-05	0.000421	CcSEcCtD
Betamethasone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	1.9e-05	0.00042	CcSEcCtD
Betamethasone—Myalgia—Mycophenolate mofetil—systemic scleroderma	1.9e-05	0.000419	CcSEcCtD
Betamethasone—Neuropathy peripheral—Prednisone—systemic scleroderma	1.89e-05	0.000419	CcSEcCtD
Betamethasone—Myocardial infarction—Prednisone—systemic scleroderma	1.89e-05	0.000419	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	1.89e-05	0.000418	CcSEcCtD
Betamethasone—Anxiety—Mycophenolate mofetil—systemic scleroderma	1.89e-05	0.000418	CcSEcCtD
Betamethasone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	1.88e-05	0.000417	CcSEcCtD
Betamethasone—Insomnia—Lisinopril—systemic scleroderma	1.88e-05	0.000415	CcSEcCtD
Betamethasone—Discomfort—Mycophenolate mofetil—systemic scleroderma	1.87e-05	0.000414	CcSEcCtD
Betamethasone—Paraesthesia—Lisinopril—systemic scleroderma	1.86e-05	0.000412	CcSEcCtD
Betamethasone—Vomiting—Captopril—systemic scleroderma	1.86e-05	0.000412	CcSEcCtD
Betamethasone—Rash—Captopril—systemic scleroderma	1.85e-05	0.000409	CcSEcCtD
Betamethasone—Dermatitis—Captopril—systemic scleroderma	1.84e-05	0.000408	CcSEcCtD
Betamethasone—Headache—Captopril—systemic scleroderma	1.83e-05	0.000406	CcSEcCtD
Betamethasone—Dyspepsia—Lisinopril—systemic scleroderma	1.83e-05	0.000404	CcSEcCtD
Betamethasone—Abdominal pain—Mycophenolic acid—systemic scleroderma	1.82e-05	0.000403	CcSEcCtD
Betamethasone—Body temperature increased—Mycophenolic acid—systemic scleroderma	1.82e-05	0.000403	CcSEcCtD
Betamethasone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	1.82e-05	0.000402	CcSEcCtD
Betamethasone—Oedema—Mycophenolate mofetil—systemic scleroderma	1.82e-05	0.000402	CcSEcCtD
Betamethasone—Infection—Mycophenolate mofetil—systemic scleroderma	1.8e-05	0.000399	CcSEcCtD
Betamethasone—Decreased appetite—Lisinopril—systemic scleroderma	1.8e-05	0.000399	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	1.79e-05	0.000396	CcSEcCtD
Betamethasone—Fatigue—Lisinopril—systemic scleroderma	1.79e-05	0.000396	CcSEcCtD
Betamethasone—Shock—Mycophenolate mofetil—systemic scleroderma	1.79e-05	0.000396	CcSEcCtD
Betamethasone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	1.78e-05	0.000394	CcSEcCtD
Betamethasone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	1.78e-05	0.000394	CcSEcCtD
Betamethasone—Pain—Lisinopril—systemic scleroderma	1.77e-05	0.000392	CcSEcCtD
Betamethasone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	1.77e-05	0.000392	CcSEcCtD
Betamethasone—Bradycardia—Prednisone—systemic scleroderma	1.76e-05	0.000391	CcSEcCtD
Betamethasone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	1.76e-05	0.000389	CcSEcCtD
Betamethasone—Diarrhoea—Azathioprine—systemic scleroderma	1.75e-05	0.000387	CcSEcCtD
Betamethasone—Haemoglobin—Prednisone—systemic scleroderma	1.74e-05	0.000386	CcSEcCtD
Betamethasone—Nausea—Captopril—systemic scleroderma	1.74e-05	0.000385	CcSEcCtD
Betamethasone—Haemorrhage—Prednisone—systemic scleroderma	1.73e-05	0.000384	CcSEcCtD
Betamethasone—Anorexia—Mycophenolate mofetil—systemic scleroderma	1.73e-05	0.000383	CcSEcCtD
Betamethasone—Asthenia—Leflunomide—systemic scleroderma	1.73e-05	0.000383	CcSEcCtD
Betamethasone—Hallucination—Prednisone—systemic scleroderma	1.72e-05	0.000382	CcSEcCtD
Betamethasone—Feeling abnormal—Lisinopril—systemic scleroderma	1.71e-05	0.000378	CcSEcCtD
Betamethasone—Pruritus—Leflunomide—systemic scleroderma	1.71e-05	0.000378	CcSEcCtD
Betamethasone—Hypotension—Mycophenolate mofetil—systemic scleroderma	1.7e-05	0.000376	CcSEcCtD
Betamethasone—Gastrointestinal pain—Lisinopril—systemic scleroderma	1.7e-05	0.000375	CcSEcCtD
Betamethasone—Dizziness—Azathioprine—systemic scleroderma	1.69e-05	0.000374	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	1.66e-05	0.000366	CcSEcCtD
Betamethasone—Asthenia—Mycophenolic acid—systemic scleroderma	1.65e-05	0.000366	CcSEcCtD
Betamethasone—Diarrhoea—Leflunomide—systemic scleroderma	1.65e-05	0.000365	CcSEcCtD
Betamethasone—Urticaria—Lisinopril—systemic scleroderma	1.65e-05	0.000365	CcSEcCtD
Betamethasone—Insomnia—Mycophenolate mofetil—systemic scleroderma	1.64e-05	0.000364	CcSEcCtD
Betamethasone—Body temperature increased—Lisinopril—systemic scleroderma	1.64e-05	0.000363	CcSEcCtD
Betamethasone—Abdominal pain—Lisinopril—systemic scleroderma	1.64e-05	0.000363	CcSEcCtD
Betamethasone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	1.63e-05	0.000361	CcSEcCtD
Betamethasone—Pruritus—Mycophenolic acid—systemic scleroderma	1.63e-05	0.00036	CcSEcCtD
Betamethasone—Vomiting—Azathioprine—systemic scleroderma	1.62e-05	0.00036	CcSEcCtD
Betamethasone—Eye disorder—Prednisone—systemic scleroderma	1.62e-05	0.000358	CcSEcCtD
Betamethasone—Rash—Azathioprine—systemic scleroderma	1.61e-05	0.000357	CcSEcCtD
Betamethasone—Dermatitis—Azathioprine—systemic scleroderma	1.61e-05	0.000356	CcSEcCtD
Betamethasone—Headache—Azathioprine—systemic scleroderma	1.6e-05	0.000354	CcSEcCtD
Betamethasone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	1.6e-05	0.000354	CcSEcCtD
Betamethasone—Dizziness—Leflunomide—systemic scleroderma	1.6e-05	0.000353	CcSEcCtD
Betamethasone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	1.58e-05	0.00035	CcSEcCtD
Betamethasone—Diarrhoea—Mycophenolic acid—systemic scleroderma	1.58e-05	0.000349	CcSEcCtD
Betamethasone—Angiopathy—Prednisone—systemic scleroderma	1.57e-05	0.000348	CcSEcCtD
Betamethasone—Conjunctivitis—Methotrexate—systemic scleroderma	1.57e-05	0.000347	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	1.57e-05	0.000347	CcSEcCtD
Betamethasone—Pain—Mycophenolate mofetil—systemic scleroderma	1.55e-05	0.000344	CcSEcCtD
Betamethasone—Arrhythmia—Prednisone—systemic scleroderma	1.55e-05	0.000343	CcSEcCtD
Betamethasone—Vomiting—Leflunomide—systemic scleroderma	1.53e-05	0.00034	CcSEcCtD
Betamethasone—Alopecia—Prednisone—systemic scleroderma	1.53e-05	0.000339	CcSEcCtD
Betamethasone—Dizziness—Mycophenolic acid—systemic scleroderma	1.52e-05	0.000337	CcSEcCtD
Betamethasone—Rash—Leflunomide—systemic scleroderma	1.52e-05	0.000337	CcSEcCtD
Betamethasone—Dermatitis—Leflunomide—systemic scleroderma	1.52e-05	0.000336	CcSEcCtD
Betamethasone—Nausea—Azathioprine—systemic scleroderma	1.52e-05	0.000336	CcSEcCtD
Betamethasone—Headache—Leflunomide—systemic scleroderma	1.51e-05	0.000335	CcSEcCtD
Betamethasone—Erythema—Prednisone—systemic scleroderma	1.51e-05	0.000334	CcSEcCtD
Betamethasone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	1.5e-05	0.000331	CcSEcCtD
Betamethasone—Asthenia—Lisinopril—systemic scleroderma	1.49e-05	0.000329	CcSEcCtD
Betamethasone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	1.49e-05	0.000329	CcSEcCtD
Betamethasone—Pruritus—Lisinopril—systemic scleroderma	1.47e-05	0.000325	CcSEcCtD
Betamethasone—Vomiting—Mycophenolic acid—systemic scleroderma	1.46e-05	0.000324	CcSEcCtD
Betamethasone—Haemoglobin—Methotrexate—systemic scleroderma	1.46e-05	0.000322	CcSEcCtD
Betamethasone—Rash—Mycophenolic acid—systemic scleroderma	1.45e-05	0.000321	CcSEcCtD
Betamethasone—Dermatitis—Mycophenolic acid—systemic scleroderma	1.45e-05	0.000321	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—systemic scleroderma	1.45e-05	0.000321	CcSEcCtD
Betamethasone—Urticaria—Mycophenolate mofetil—systemic scleroderma	1.44e-05	0.000319	CcSEcCtD
Betamethasone—Headache—Mycophenolic acid—systemic scleroderma	1.44e-05	0.000319	CcSEcCtD
Betamethasone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	1.44e-05	0.000318	CcSEcCtD
Betamethasone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	1.44e-05	0.000318	CcSEcCtD
Betamethasone—Nausea—Leflunomide—systemic scleroderma	1.43e-05	0.000317	CcSEcCtD
Betamethasone—Diarrhoea—Lisinopril—systemic scleroderma	1.42e-05	0.000314	CcSEcCtD
Betamethasone—Ill-defined disorder—Prednisone—systemic scleroderma	1.4e-05	0.00031	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—systemic scleroderma	1.4e-05	0.000309	CcSEcCtD
Betamethasone—Angioedema—Prednisone—systemic scleroderma	1.38e-05	0.000305	CcSEcCtD
Betamethasone—Dizziness—Lisinopril—systemic scleroderma	1.37e-05	0.000303	CcSEcCtD
Betamethasone—Nausea—Mycophenolic acid—systemic scleroderma	1.37e-05	0.000303	CcSEcCtD
Betamethasone—Malaise—Prednisone—systemic scleroderma	1.36e-05	0.000301	CcSEcCtD
Betamethasone—Vertigo—Prednisone—systemic scleroderma	1.36e-05	0.0003	CcSEcCtD
Betamethasone—Eye disorder—Methotrexate—systemic scleroderma	1.35e-05	0.0003	CcSEcCtD
Betamethasone—Syncope—Prednisone—systemic scleroderma	1.35e-05	0.000299	CcSEcCtD
Betamethasone—Loss of consciousness—Prednisone—systemic scleroderma	1.33e-05	0.000294	CcSEcCtD
Betamethasone—Vomiting—Lisinopril—systemic scleroderma	1.32e-05	0.000292	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—systemic scleroderma	1.31e-05	0.000291	CcSEcCtD
Betamethasone—Rash—Lisinopril—systemic scleroderma	1.31e-05	0.000289	CcSEcCtD
Betamethasone—Convulsion—Prednisone—systemic scleroderma	1.31e-05	0.000289	CcSEcCtD
Betamethasone—Dermatitis—Lisinopril—systemic scleroderma	1.31e-05	0.000289	CcSEcCtD
Betamethasone—Asthenia—Mycophenolate mofetil—systemic scleroderma	1.3e-05	0.000288	CcSEcCtD
Betamethasone—Hypertension—Prednisone—systemic scleroderma	1.3e-05	0.000288	CcSEcCtD
Betamethasone—Headache—Lisinopril—systemic scleroderma	1.3e-05	0.000287	CcSEcCtD
Betamethasone—Pruritus—Mycophenolate mofetil—systemic scleroderma	1.29e-05	0.000284	CcSEcCtD
Betamethasone—Myalgia—Prednisone—systemic scleroderma	1.28e-05	0.000284	CcSEcCtD
Betamethasone—Anxiety—Prednisone—systemic scleroderma	1.28e-05	0.000283	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—systemic scleroderma	1.28e-05	0.000283	CcSEcCtD
Betamethasone—Discomfort—Prednisone—systemic scleroderma	1.27e-05	0.000281	CcSEcCtD
Betamethasone—Erythema—Methotrexate—systemic scleroderma	1.26e-05	0.000279	CcSEcCtD
Betamethasone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	1.24e-05	0.000275	CcSEcCtD
Betamethasone—Nausea—Lisinopril—systemic scleroderma	1.23e-05	0.000273	CcSEcCtD
Betamethasone—Anaphylactic shock—Prednisone—systemic scleroderma	1.23e-05	0.000273	CcSEcCtD
Betamethasone—Oedema—Prednisone—systemic scleroderma	1.23e-05	0.000273	CcSEcCtD
Betamethasone—Infection—Prednisone—systemic scleroderma	1.22e-05	0.000271	CcSEcCtD
Betamethasone—Shock—Prednisone—systemic scleroderma	1.21e-05	0.000268	CcSEcCtD
Betamethasone—Nervous system disorder—Prednisone—systemic scleroderma	1.21e-05	0.000267	CcSEcCtD
Betamethasone—Tachycardia—Prednisone—systemic scleroderma	1.2e-05	0.000266	CcSEcCtD
Betamethasone—Dizziness—Mycophenolate mofetil—systemic scleroderma	1.2e-05	0.000266	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—systemic scleroderma	1.19e-05	0.000263	CcSEcCtD
Betamethasone—Anorexia—Prednisone—systemic scleroderma	1.17e-05	0.00026	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—systemic scleroderma	1.17e-05	0.000259	CcSEcCtD
Betamethasone—Vomiting—Mycophenolate mofetil—systemic scleroderma	1.16e-05	0.000256	CcSEcCtD
Betamethasone—Rash—Mycophenolate mofetil—systemic scleroderma	1.15e-05	0.000254	CcSEcCtD
Betamethasone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.14e-05	0.000253	CcSEcCtD
Betamethasone—Headache—Mycophenolate mofetil—systemic scleroderma	1.14e-05	0.000252	CcSEcCtD
Betamethasone—Malaise—Methotrexate—systemic scleroderma	1.14e-05	0.000252	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—systemic scleroderma	1.13e-05	0.000251	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	1.12e-05	0.000248	CcSEcCtD
Betamethasone—Insomnia—Prednisone—systemic scleroderma	1.11e-05	0.000247	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—systemic scleroderma	1.11e-05	0.000245	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—systemic scleroderma	1.09e-05	0.000242	CcSEcCtD
Betamethasone—Dyspepsia—Prednisone—systemic scleroderma	1.08e-05	0.00024	CcSEcCtD
Betamethasone—Nausea—Mycophenolate mofetil—systemic scleroderma	1.08e-05	0.000239	CcSEcCtD
Betamethasone—Myalgia—Methotrexate—systemic scleroderma	1.07e-05	0.000238	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—systemic scleroderma	1.07e-05	0.000237	CcSEcCtD
Betamethasone—Fatigue—Prednisone—systemic scleroderma	1.06e-05	0.000235	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—systemic scleroderma	1.06e-05	0.000235	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—systemic scleroderma	1.03e-05	0.000228	CcSEcCtD
Betamethasone—Infection—Methotrexate—systemic scleroderma	1.02e-05	0.000226	CcSEcCtD
Betamethasone—Feeling abnormal—Prednisone—systemic scleroderma	1.01e-05	0.000225	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—systemic scleroderma	1.01e-05	0.000223	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—systemic scleroderma	1.01e-05	0.000223	CcSEcCtD
Betamethasone—Gastrointestinal pain—Prednisone—systemic scleroderma	1.01e-05	0.000223	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—systemic scleroderma	9.95e-06	0.00022	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—systemic scleroderma	9.81e-06	0.000217	CcSEcCtD
Betamethasone—Urticaria—Prednisone—systemic scleroderma	9.78e-06	0.000217	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—systemic scleroderma	9.73e-06	0.000215	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—systemic scleroderma	9.73e-06	0.000215	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—systemic scleroderma	9.62e-06	0.000213	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	9.38e-06	0.000208	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—systemic scleroderma	9.31e-06	0.000206	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—systemic scleroderma	9.24e-06	0.000205	CcSEcCtD
Betamethasone—Dyspepsia—Methotrexate—systemic scleroderma	9.06e-06	0.0002	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—systemic scleroderma	8.95e-06	0.000198	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.88e-06	0.000197	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—systemic scleroderma	8.87e-06	0.000196	CcSEcCtD
Betamethasone—Asthenia—Prednisone—systemic scleroderma	8.84e-06	0.000196	CcSEcCtD
Betamethasone—Pain—Methotrexate—systemic scleroderma	8.8e-06	0.000195	CcSEcCtD
Betamethasone—Pruritus—Prednisone—systemic scleroderma	8.71e-06	0.000193	CcSEcCtD
Betamethasone—Feeling abnormal—Methotrexate—systemic scleroderma	8.48e-06	0.000188	CcSEcCtD
Betamethasone—Diarrhoea—Prednisone—systemic scleroderma	8.43e-06	0.000186	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.42e-06	0.000186	CcSEcCtD
Betamethasone—Urticaria—Methotrexate—systemic scleroderma	8.18e-06	0.000181	CcSEcCtD
Betamethasone—Dizziness—Prednisone—systemic scleroderma	8.14e-06	0.00018	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—systemic scleroderma	8.14e-06	0.00018	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—systemic scleroderma	8.14e-06	0.00018	CcSEcCtD
Betamethasone—Vomiting—Prednisone—systemic scleroderma	7.83e-06	0.000173	CcSEcCtD
Betamethasone—Rash—Prednisone—systemic scleroderma	7.76e-06	0.000172	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—systemic scleroderma	7.76e-06	0.000172	CcSEcCtD
Betamethasone—Headache—Prednisone—systemic scleroderma	7.71e-06	0.000171	CcSEcCtD
Betamethasone—Asthenia—Methotrexate—systemic scleroderma	7.38e-06	0.000163	CcSEcCtD
Betamethasone—Nausea—Prednisone—systemic scleroderma	7.31e-06	0.000162	CcSEcCtD
Betamethasone—Pruritus—Methotrexate—systemic scleroderma	7.28e-06	0.000161	CcSEcCtD
Betamethasone—Diarrhoea—Methotrexate—systemic scleroderma	7.04e-06	0.000156	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—systemic scleroderma	6.81e-06	0.000151	CcSEcCtD
Betamethasone—Vomiting—Methotrexate—systemic scleroderma	6.54e-06	0.000145	CcSEcCtD
Betamethasone—Rash—Methotrexate—systemic scleroderma	6.49e-06	0.000144	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—systemic scleroderma	6.48e-06	0.000143	CcSEcCtD
Betamethasone—Headache—Methotrexate—systemic scleroderma	6.45e-06	0.000143	CcSEcCtD
Betamethasone—Nausea—Methotrexate—systemic scleroderma	6.11e-06	0.000135	CcSEcCtD
